Australian share market turns red for 2023
James Dunn
October 24, 2023
The Australian stock market has given up all of the
CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
The Australian stock market has given up all of the
CSL Limited (ASX: CSL) is currently trading at a 1-yr
Will Ozempic sink ResMed Inc (ASX:RMD) and CSL Limited (ASX:CSL)?
The local share market snapped its losing streak, with both
Both the key Australian indices fell on Monday, with the
Here’s today’s The Match Out report from Market Matters’ James
Here’s today’s The Match Out report from Market Matters’ James
Sonic Healthcare Ltd (ASX: SHL) has traditionally viewed as an
The Australian sharemarket rebounded from 11-month lows on Thursday, notching
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
